Table 2

African countries that have approved COVID-19 vaccination for children and adolescents*

Vaccine typeVaccine nameManufacturer and countryWHO emergency use listing?*21CountryApproval date for paediatric usePaediatric age indication (years)
1messenger RNA (mRNA)BNT162b2Pfizer-BioNTech (USA/Germany)YesUganda
Mauritius
Morocco
Seychelles
South Africa
Guinea Conakry
Namibia
Ghana
Egypt
Egypt
Nigeria
26 July 202136
August 202137
31 August 202137
9 September 202138
10 September 202139
10 November 202138
12 November 202140
16 November 202141
2 November 202142
28 November 202143
14 January 202244
12–17
12–17
12–17
12–17
12–17
12–17
12–17
15–17
15–18
12–15
16–17
2mRNA-1273Moderna (USA)YesGuinea Conakry
Nigeria
10 November 202138
14 January 202244
12–17
16–17
3Viral vectorAd26.COV2.SJohnson & Johnson/Janssen (USA/Belgium)YesNigeria14 January 20224416–17
4AZD1222Oxford-AstraZeneca (UK)YesNigeria14 January 20224416–17
5CovishieldSerum Institute of IndiaYesNigeria14 January 20224416–17
6Sputnik LightGamaleya (Russia)NoNone
7Sputnik VGamaleya (Russia)NoNigeria14 January 20224416–17
8Inactivated virusBBIBP-CorVSinopharm (China)YesMorocco
Nigeria
31 August 202137
14 January 202244
12–17
16–17
9CoronaVacSinovac (China)YesZimbabwe1 November 20214516–17
10CovaxinBharat Biotech (India)YesNone
11Protein basedCorbevaxBiological-E (India)NoNone
12CovovaxSerum Institute of India (India)YesNone
13NVX-CoV2373Novavax (USA)YesNone
14DNAZyCoV-DZydus Cadila (India)NoNone
  • *As of 14 January 2022.

  • †Waiver granted for 16 and 17 year-olds to get any available COVID-19 vaccine if needed for educational (e.g school vaccine mandate, international institution admission/attendance requirements) and international travel purposes. Approvals in table indicated for vaccines currently available in Nigeria.4